13F
← All fund report cards

SUMITOMO LIFE INSURANCE CO

13F equity value
$4.3B
Positions
282
Top 10 concentration
69.8%
Quarters / total new picks
32 / 176
13F equity value over time
$0M$3B$5B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +6.1% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 0.80, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+3.3%
t-stat
0.80
Quarterly win rate
56%
Annualized excess
+11.1%
$1 → follow vs universe
$4.50 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.00820180630: follow 0.92020180930: follow 0.97520181231: follow 1.02520190331: follow 1.00920190630: follow 1.14420190930: follow 1.33720191231: follow 1.20420200331: follow 1.49320200630: follow 1.56820200930: follow 1.75520201231: follow 1.66020210331: follow 1.88020210630: follow 2.10820210930: follow 1.83620211231: follow 1.47820220331: follow 2.80820220630: follow 2.87020220930: follow 3.00020221231: follow 3.44020230331: follow 3.54220230630: follow 3.57320230930: follow 4.54820231231: follow 4.16720240331: follow 4.35120240630: follow 4.69520240930: follow 5.05220241231: follow 4.94220250331: follow 5.15520250630: follow 5.04620250930: follow 4.10020251231: follow 4.501 0.84 3.20 5.57 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 282 · 2026 Q1

Ticker Value Weight QoQ
SCHD $1.4B
32.8%
ADD
IVV $672M
15.8%
ADD
TIP $167M
3.9%
NEW
PBP $137M
3.2%
HOLD
EMB $126M
2.9%
TRIM
NVDA $111M
2.6%
ADD
AAPL $90M
2.1%
ADD
GOOGL $74M
1.7%
ADD
XYLD $67M
1.6%
HOLD
MSFT $66M
1.6%
TRIM
AMZN $56M
1.3%
HOLD
AVGO $40M
0.9%
ADD
BKLN $38M
0.9%
TRIM
VWO $37M
0.9%
TRIM
LLY $36M
0.8%
ADD
JPM $30M
0.7%
ADD
VWOB $29M
0.7%
TRIM
META $26M
0.6%
TRIM
SCHP $25M
0.6%
TRIM
VOO $25M
0.6%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.